cross-reactivity – Page 9 – Communicable Diseases Research

Diagnostic Value of a SARS-CoV-2 Rapid Test Kit for Detection of Neutralizing Antibodies as a Point-of-Care Surveillance Test

현장 감시 검사로서 중화 항체 검출을 위한 SARS-CoV-2 신속 검사 키트의 진단 가치

Article

Published on 2022-04-272022-09-11
Journal: Microbiology Spectrum [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술,

Safety and immunogenicity of the Pfizer/BioNTech SARS-CoV-2 mRNA third booster vaccine dose against the BA.1 and BA.2 Omicron variants

BA.1 및 BA.2 Omicron 변이체에 대한 Pfizer/BioNTech SARS-CoV-2 mRNA 3차 부스터 백신 용량의 안전성 및 면역원성

Clinical and Translational Article

Published on 2022-04-262022-09-14
Journal: Med (New York, N.Y.) [Category] COVID19(2023년), MERS, SARS, 변종, 임상, 진단,

[키워드] Abstract adverse event AMED anti-spike antibody BA.1 BA.1.1 BA.2 BNT162b2 mRNA vaccine booster booster vaccination Booster vaccine breadth changes in Context cross-reactivity cytokine cytokine signature Delta dose evaluate evaluated finding funding groups healthcare worker Humoral immunity immunogenicity increase increase in individual Japan Live virus microneutralization mRNA mRNA vaccination Mutation neutralization neutralization ability Neutralization antibody neutralization titer Neutralizing Neutralizing antibodies neutralizing antibody no significant difference omicron Pfizer/BioNTech robust Safe Safety SARS-CoV-2 SARS-CoV-2 variants second vaccination sera significantly lower Spike protein subvariant supported the spike protein vaccination Vaccine vaccine dose Vaccine-induced immunity vaccinee variant variant of concern variants variants of concern VoC VOCs
[DOI] 10.1016/j.medj.2022.04.013 PMC 바로가기 [Article Type] Clinical and Translational Article

Long-Term, CD4 + Memory T Cell Response to SARS-CoV-2

SARS-CoV-2에 대한 장기 CD4 + 메모리 T 세포 반응

Article

Published on 2022-04-202022-09-11
Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, 진단, 치료법,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Affect Antibody titers Antigen caused CD4 Chinese Cohort composed convalescent convalescent individual convalescent individuals coronavirus coronavirus disease Coronavirus disease-19 Coronaviruses COVID-19 cross-reactive cross-reactivity demonstrated disease spread Endemic Factor global pandemic HCoV healthcare worker Humoral immunity immune response immune responses Immunity include individuals Infection long-term memory long-term memory. memory NL63 nucleocapsid nucleocapsid antigen OC43 onset of symptoms Prevent protective immunity recruited reported respiratory respond response SARS-CoV-2 severe acute respiratory syndrome Coronavirus Spike protein study period T cell T cell immunity T cell memory T cell response T cells the spike protein Vaccine design Viral viral spread
[DOI] 10.3389/fimmu.2022.800070 PMC 바로가기 [Article Type] Article

Microfluidic Antibody Affinity Profiling Reveals the Role of Memory Reactivation and Cross-Reactivity in the Defense Against SARS-CoV-2

미세유체 항체 친화성 프로파일링은 SARS-CoV-2에 대한 방어에서 기억 재활성화 및 교차 반응성의 역할을 보여줍니다

Article

Published on 2022-04-082022-09-12
Journal: ACS Infectious Diseases [Category] COVID19(2023년), MERS, SARS, 진단,

[키워드] acute SARS-CoV-2 infection ADE adverse effect affinity Against antibody antibody affinity antibody concentration antibody profiling Antibody-dependent enhancement Antigen Concentration convalescent coronavirus Course COVID-19 COVID-19 convalescent patient COVID-19 patient cross-reactive antibodies cross-reactive antibody cross-reactivity Determining detrimental effect effort ELISAs endemic human coronavirus enzyme-linked immunosorbent assay evaluate HCoV-HKU1 HCoV-NL63 humoral immune response Immunity Infection memory memory B-cell memory immunity Microfluidics new SARS-CoV-2 nine parameter Pathogens Profiling Reactivation recent role SARS-CoV-2 SARS-COV-2 infection sequence similarity sera seropositive severity Spike protein the SARS-CoV-2
[DOI] 10.1021/acsinfecdis.1c00486 PMC 바로가기 [Article Type] Article

Frequent Infection of Cats With SARS-CoV-2 Irrespective of Pre-Existing Enzootic Coronavirus Immunity, Brazil 2020

기존의 Enzootic 코로나 바이러스 면역과 관계없이 SARS-CoV-2에 고양이의 빈번한 감염, 브라질 2020

Article

Published on 2022-04-052022-09-11
Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, 변종, 진단,

[키워드] 95% CI Affect affected Antibody titer Antibody titers B.1 Bovine coronavirus Brazil carnivore cats cats (felis catus) coronavirus COVID-19 cross-reactivity elicited Endemic ENhance Gamma homogeneous hot spot human immunity immune response immune responses Infection infection level investigated magnitude neutralization test Neutralizing antibody titer neutralizing antibody titers no significant difference pandemic plaque reduction neutralization Plaque reduction neutralization test pre-existing immunity prevents PRNT raise SARS-CoV-2 SARS-CoV-2 antibody SARS-COV-2 infection SARS-CoV-2 mutation SARS-CoV-2 seroprevalence serology Seroprevalence serostatus Seven significant difference significantly higher significantly lower Spread susceptible Transmission variant zoonosis
[DOI] 10.3389/fimmu.2022.857322 PMC 바로가기 [Article Type] Article

Coronavirus Disease 2019 Messenger RNA Vaccine Immunogenicity in Immunosuppressed Individuals

코로나바이러스 질병 2019 메신저 RNA 백신 면역억제된 개인의 면역원성

Article

Published on 2022-04-012022-09-11
Journal: The Journal of Infectious Diseases [Category] COVID19(2023년), SARS, 변종, 진단,

[키워드] 19 vaccine 2 acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 addition antibody Antibody Response Antibody responses binding CD4 CD8 T-cell coronavirus coronavirus disease Coronavirus disease 2019 CoV COVID COVID-19 COVID-19 mRNA Vaccination cross-reactivity function Immunocompromised immunocompromised individuals immunogenicity immunosuppressive increased mortality individual individuals Infection interferon interferon-γ lead messenger Messenger RNA mRNA mRNA vaccination mRNA vaccine Neutralizing reduce reduced regimen respiratory response RNA SARS SARS-CoV-2 SARS-CoV-2 variants severe acute respiratory syndrome Coronavirus T cells therapy These data vaccine immunogenicity Viral viral clearance Viral variants
[DOI] 10.1093/infdis/jiab569 PMC 바로가기 [Article Type] Article

Evaluation of the Roche-SD Biosensor rapid antigen test: Antigen is not reliable in detecting SARS-CoV-2 at the early stage of infection with respiratory symptoms

Roche-SD Biosensor 급속 항원 검사 평가: 호흡기 증상이 있는 감염 초기 단계에서 SARS-CoV-2를 검출하는 항원은 신뢰할 수 없습니다.

Article

Published on 2022-04-012022-09-11
Journal: Diagnostic microbiology and infectious disease [Category] COVID19(2023년), SARS, 치료기술,

Relapsed and newly diagnosed Graves’ disease due to immunization against COVID-19: A case series and review of the literature

코로나19 예방접종으로 인한 그레이브스병 재발 및 새로 진단: 사례 시리즈 및 문헌 고찰

Review

Published on 2022-04-012022-09-11
Journal: Journal of autoimmunity [Category] COVID19(2023년), SARS, 유전자 메커니즘, 치료기술,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 addition adjuvant adjuvants age Autoimmune Autoimmune thyroid diseases case sery causal relationship coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccination COVID-19 vaccine cross-reactivity develop diagnosed disease environmental factor environmental factors Factors female Genetic genetic factors grave Graves' disease Hashimoto Hashimoto's thyroiditis Hyperthyroidism immunization inactivated Inactivated COVID-19 vaccine Infection literature review mammalian protein manifestation mechanism mechanisms median median age molecular mRNA mRNA vaccine multicenter one patient Patient Prospective Study reported SARS-CoV-2 severe acute respiratory syndrome Coronavirus similarity symptom onset the median the patient the vaccine thought Thyroid Thyroiditis Trigger triggers viral particle Viral particles virus
[DOI] 10.1016/j.jaut.2022.102809 PMC 바로가기 [Article Type] Review

Validation of xMAP SARS-CoV-2 Multi-Antigen IgG assay in Nigeria

나이지리아에서 xMAP SARS-CoV-2 다중 항원 IgG 분석 검증

Article

Published on 2022-04-012022-09-12
Journal: PLoS ONE [Category] COVID19(2023년), SARS, 진단,

Immunoinformatics prediction of potential immunodominant epitopes from human coronaviruses and association with autoimmunity

Article

Published on 2022-04-012023-07-07
Journal: Immunogenetics [Category] COVID19(2023년),

[키워드] auto-immune disease B cell coronavirus cross-reactivity immunoinformatics T cell
[DOI] 10.1007/s00251-021-01250-5 PMC 바로가기